Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:301-308, doi:10.1016/S0735-1097(03)00627-2
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, S.
Right arrow Articles by Grayburn, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, S.
Right arrow Articles by Grayburn, P. A.

CLINICAL RESEARCH: CARDIAC ULTRASOUND

Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by Ultrasound-Targeted microbubble destruction

Shuyuan Chen, MD*, Ralph V. Shohet, MD, FACC*, Raffi Bekeredjian, MD*, Peter Frenkel, MD, FACC*, {dagger} and Paul A. Grayburn, MD, FACC*{dagger}, {ddagger},*

* Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas, Texas, USA
{dagger} Department of Veterans Affairs Medical Center, Dallas, Texas, USA
{ddagger} Baylor University Medical Center, Dallas, Texas, USA

Manuscript received November 25, 2002; revised manuscript received April 10, 2003, accepted April 14, 2003.

* Reprint requests and correspondence: Dr. Paul A. Grayburn, Director of Cardiology Research, Baylor Heart and Vascular Institute, 3500 Gaston Avenue, Dallas, Texas 75216, USA.
paulgr{at}baylorhealth.edu

OBJECTIVES: This study was undertaken to optimize echocardiographic parameters for successful gene delivery to the heart and to extend the method from adenoviral to plasmid deoxyribonucleic acid (DNA).

BACKGROUND: We have previously shown that ultrasound-targeted microbubble destruction can direct tissue expression of adenoviral transgenes to the heart. The optimal echocardiographic parameters for this technique have not been reported.

METHODS: Adenoviral or plasmid DNA encoding the luciferase reporter gene was incorporated into liposome microbubbles and infused intravenously into anesthetized rats. We systematically evaluated the effects of ultrasound parameters known to influence microbubble destruction, including electrocardiogram (ECG) triggering, ultrasound frequency, mode of ultrasound, and mechanical index, on gene expression in rat myocardium four days after treatment. In addition, gene expression in heart, liver, and skeletal muscle were compared between adenoviral and plasmid DNA.

RESULTS: Optimal ultrasound parameters for this technique include low-transmission frequency (1.3 MHz), maximal mechanical index, and ECG triggering to allow complete filling of the myocardial capillary bed by microbubbles. No difference was seen between ultraharmonics and power Doppler mode. Using adenoviral DNA, optimal ultrasound parameters yielded myocardial luciferase activity on the order of 104 relative light units/mg protein/min but with even higher liver activity. Plasmid DNA was expressed in rat myocardium at similar levels but without detectable liver expression.

CONCLUSIONS: Ultrasound-targeted microbubble destruction can be used to deliver adenoviral or plasmid DNA to the myocardium. This technique holds great promise in applying the rapidly expanding repertoire of gene therapies being developed for cardiac disease.

Abbreviations and Acronyms
  AdCMV-luc
  adenovirus encoding the luciferase gene under a cytomegalovirus promoter
  ANOVA
  analysis of variance
  DNA
  deoxyribonucleic acid
  ECG
  electrocardiogram/electrocardiograph/ electrocardiographic
  LV
  left ventricle/ventricular
  UTMD
  ultrasound-targeted microbubble destruction




This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
S. Kaul
Myocardial Contrast Echocardiography: A Wondrous Journey!
J. Am. Coll. Cardiol. Img., February 1, 2010; 3(2): 212 - 218.
[Full Text] [PDF]


Home page
Acta Biochim Biophys SinHome page
S. Xenariou, H.-D. Liang, U. Griesenbach, J. Zhu, R. Farley, L. Somerton, C. Singh, P. K. Jeffery, R. K. Scheule, S. H. Cheng, et al.
Low-frequency ultrasound increases non-viral gene transfer to the mouse lung
Acta Biochim Biophys Sin, January 1, 2010; 42(1): 45 - 51.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
J. J. Escobar-Chavez, D. Bonilla-Martinez, M. A. Villegas-Gonzalez, and A. L. Revilla-Vazquez
Electroporation as an Efficient Physical Enhancer for Skin Drug Delivery
J. Clin. Pharmacol., November 1, 2009; 49(11): 1262 - 1283.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Kobulnik, M. A. Kuliszewski, D. J. Stewart, J. R. Lindner, and H. Leong-Poi
Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection.
J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1735 - 1742.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
H. Fujii, Z. Sun, S.-H. Li, J. Wu, S. Fazel, R. D. Weisel, H. Rakowski, J. Lindner, and R.-K. Li
Ultrasound-Targeted Gene Delivery Induces Angiogenesis After a Myocardial Infarction in Mice
J. Am. Coll. Cardiol. Img., July 1, 2009; 2(7): 869 - 879.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
J. A. Kopechek, T. M. Abruzzo, B. Wang, S. M. Chrzanowski, D. A. B. Smith, P. H. Kee, S. Huang, J. H. Collier, D. D. McPherson, and C. K. Holland
Ultrasound-Mediated Release of Hydrophilic and Lipophilic Agents From Echogenic Liposomes
J. Ultrasound Med., November 1, 2008; 27(11): 1597 - 1606.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
D. L. Miller, M. A. Averkiou, A. A. Brayman, E. C. Everbach, C. K. Holland, J. H. Wible Jr, and J. Wu
Bioeffects Considerations for Diagnostic Ultrasound Contrast Agents
J. Ultrasound Med., April 1, 2008; 27(4): 611 - 632.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
X. Li, Z. Wang, H. Ran, X. Li, Q. Yuan, Y. Zheng, J. Ren, L. Su, W. Zhang, Q. Li, et al.
Experimental Research on Therapeutic Angiogenesis Induced by Hepatocyte Growth Factor Directed by Ultrasound-Targeted Microbubble Destruction in Rats
J. Ultrasound Med., March 1, 2008; 27(3): 453 - 460.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A R Lyon, M Sato, R J Hajjar, R J Samulski, and S E Harding
Gene therapy: targeting the myocardium
Heart, January 1, 2008; 94(1): 89 - 99.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. J. Muller, H. A. Katus, and R. Bekeredjian
Targeting the heart with gene therapy-optimized gene delivery methods
Cardiovasc Res, February 1, 2007; 73(3): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Chen, J.-h. Ding, R. Bekeredjian, B.-z. Yang, R. V. Shohet, S. A. Johnston, H. E. Hohmeier, C. B. Newgard, and P. A. Grayburn
Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology
PNAS, May 30, 2006; 103(22): 8469 - 8474.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Vancraeynest, X. Havaux, A.-C. Pouleur, A. Pasquet, B. Gerber, C. Beauloye, P. Rafter, L. Bertrand, and J.-L. J. Vanoverschelde
Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction
Eur. Heart J., January 2, 2006; 27(2): 237 - 245.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Yoshida, K. Ohmori, H. Takeuchi, K. Shinomiya, T. Namba, I. Kondo, H. Kiyomoto, and M. Kohno
Treatment of Ischemic Limbs Based on Local Recruitment of Vascular Endothelial Growth Factor-Producing Inflammatory Cells With Ultrasonic Microbubble Destruction
J. Am. Coll. Cardiol., September 6, 2005; 46(5): 899 - 905.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
S. Chapman, J. Windle, F. Xie, A. McGrain, and T. R. Porter
Incidence of Cardiac Arrhythmias With Therapeutic Versus Diagnostic Ultrasound and Intravenous Microbubbles
J. Ultrasound Med., August 1, 2005; 24(8): 1099 - 1107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. A. Dean
Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals
Am J Physiol Cell Physiol, August 1, 2005; 289(2): C233 - C245.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. M. Dittmar, J. Xie, F. Hunter, C. Trimble, M. Bur, V. Frenkel, and K. C. P. Li
Pulsed High-Intensity Focused Ultrasound Enhances Systemic Administration of Naked DNA in Squamous Cell Carcinoma Model: Initial Experience
Radiology, May 1, 2005; 235(2): 541 - 546.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Bekeredjian, P. A. Grayburn, and R. V. Shohet
Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine
J. Am. Coll. Cardiol., February 1, 2005; 45(3): 329 - 335.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Weyman
The year in echocardiography
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 140 - 148.
[Full Text] [PDF]


Home page
Br. J. Radiol.Home page
H-D Liang and M J K Blomley
The role of ultrasound in molecular imaging
Br. J. Radiol., December 1, 2003; 76(suppl_2): S140 - S150.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Bekeredjian, S. Chen, P. A. Frenkel, P. A. Grayburn, and R. V. Shohet
Ultrasound-Targeted Microbubble Destruction Can Repeatedly Direct Highly Specific Plasmid Expression to the Heart
Circulation, August 26, 2003; 108(8): 1022 - 1026.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement